To evaluate the adaptation of electrodermal techniques for cystic fibrosis screening, skin surface bioelectric measurements were recorded from 37 established cystic fibrosis patients, 45 asthmatic patients, and 10 normal controls, ranging in age from 6 to 22 yr. Six skin potential and six skin conductance measures of sweat gland activity without the collection of sweat distinguished between the cystic fibrosis, normal, and asthmatic groups (F ratios > 10.0; p < 0.0001). Discriminant analysis using the two best electrodermal measures (the mean of five preresponse potential levels and the mean of five preresponse conductance levels for each subject) to assign experimental group membership matched actual group membership with 92.7% accuracy. We believe these results warrant further investigation of electrodermal procedures as a direct, simple, yet noninvasive means of screening for cystic fibrosis. 
epidermal skin potential and skin conductance bioelectric measukments for the clinical purpose of preliminary cystic fibrosis screening. These electrodermal measurements. which are relau tively simple to obtain, are sensitive to sweat gland activity in amounts too small to produce surface sweating (3) (4) (5) (6) (7) (8) . These microdischarges of sweat transiently alter the standing electric SPL and SCL, producing a SPR and a SPR (see Figs. 1 and 2) . ' The eccrine sweat glands in palmar and plantar skin are activated by a range of sensory, emotional, and physiologic (e.g. deep breaths) stimuli, facilitating noninvasive assessment.
The well-known increase in sweat sodium chloride in cystic fibrosis is accompanied by a less well-known increase in sweat ductal lumen negativity relative to interstitial fluid. Maximally stimulated individual sweat tubules generate a greater lumen negative bioelectric potential relative t i interstitial-fluid in cystic fibrosis patients (9) . Consistent with the hypothesis of reduced permeability to the reabsorption of chloride (9) , nasal epithelium from cystic fibrosis polyps has a higher electrical resistance than normal turbinate epithelium (10) .
Our purpose was to evaluate the validity of discriminating between cystic fibrosis patients and asthmatic or normal controls by means of transepidermal skin surface bioelectric recordings in a pediatric clinical setting. In addition to the measurement of SPL with activated sweat glands, which is most comparable to previous reports of greater lumen negativity, new dimensions are added by the assessment of SPRs and of both SCLs and SCRs. SCL and SCR were expected to be influenced by the higher salt content of cystic sweat, which should promote greater conductance via both the sweat gland and the nonsudorific pathways through the epidermis.
METHODS

S1~bject
.s. Electrodermal measures were recorded from 114 patients including 50 cystic fibrosis patients, 54 asthmatic patients, and 10 normal controls between 4 and 22 yr of age. The mean value of previously collected sweat tests for 37 cystic Table I ). The response amplitude (nos. 4, 5, 6 in Table 1 ) is point A minus point B. Table 2 ). The response amplitude (nos. 10 and I I in Table 2 ) is point H minus point A . All values have been converted to a standard surface area and reported as microsiemens per cm2 in Table 2. fibrosis patients was 101.7 mEq/liter (range 7 1 to 220) and for the 17 asthmatic patients for whom results were available was 15.2 mEq/liter (range 4.4 to 33.5). Six subjects' electrodermal data were difficult to interpret due to technical difficulties, and all ten 4-and 5-yr-old subjects (seven cystic fibrosis and three asthma) were excluded from the primary analysis because some were unable to follow all the instructions. In addition, six subjects were not included in the analysis because of low effort in the series of fast, deep breaths employed to induce palmar sweat gland responses. "Low effort" was operationally defined as skin conductance responses which were less than 30% of the maximum conductance response elicited by the balloon pop-startle stimulus described below. Therefore, satisfactory recordings for 92 subjects were included in the primary analysis-37 cystic fibrosis patients, 45 asthmatic patients, and 10 normal controls.
Medicatron. Because some medications may alter sweat gland functioning, an attempt was made to record subjects in as drugfree a state as possible. However, since 12 cystic fibrosis patients and 38 asthmatic patients required adrenergic, theophylline, and steroid medication, the data from these subjects were compared to those of the drug-free subjects in the statistical analysis. Procedure After cleaning the skin with isopropyl alcohol and air-drying, Beckman silver/silver chloride electrodes (contact area = 0.636 cm') were applied to the palmar surface of the fingers. For measures of potential, a sandpaper-abraded reference site 3 cm distal to the olecranon along the ulna was used (1 I:), with the active electrode being placed on the palmar surface of the distal middle phalanx of the hand. The contact medium for potential measures was 0.05 M sodium chloride in a mixture of 50% Unibase (a cold cream base marketed by Parke-Davis) and 50% polyethylene glycol (mol wt 400 to 600), to keep the stratum corneum minimally hydrated (12, 13) . For skin conductance measures, 0.5 V was applied in conjunction with a Wheatstone Bridge circuit to the palmar surface of two adjacent distal pha.-langes via a medium consisting of 0.05 M sodium chloride in a Unibase-water mixture, and the conductance was measured as the voltage across a small resistor in series with the skin (1411. Two direct current low voltage channels of a Grass model ' 7 polygraph recorded the skin potential and skin conductance tracings simultaneously for one series of stimuli given to each subject. After the leads were attached, the presence of an intact circuit was verified by having subjects take a fast, deep breath. This physiologic stimulus reliably elicits a sweat gland response in palmar and plantar skin, and was used as a baseline test response. Next, a 10-min rest period allowed the electrolyte-skin interface to reach an approximate equilibrium at minimum standin:g levels. The instruction that the rest period was over produced ;a gradual increase in both the potential (i.e. greater surface negativity) and conductance levels over 30 s, associated with the sweat gland response to this stimulus. When the levels stabilized at th~e higher level, a series of stimuli were presented by asking for fast, deep breaths. Each breath simultaneously produced a large SCF: and a large positive-going (i.e. decreased negativity) SPR on the tracing (Figs. 1 and 2). These breaths were spaced judiciously to coincide with the peak of the recovery from the previous SPR, following a procedure designed to produce large positive SPRs (15, 16) . The deep breaths were requested until five clear positive SPRs were obtained and until exhorting the subject to take faster, deeper breaths or startling him/her by clapped hands elicited only smaller responses.
Because of the possibility that adequate responses would not be elicited if patients failed to take deep enough breaths (i.e.
showed too little effort), a startle response was also elicited by asking patients to blow up a balloon (with eyes closed) until it popped unexpectedly. As noted above, six patients were excludeti from the analysis for giving "low effort breaths."
Electrodernzul measures. The potential measures scored froni the polygraph record in millivolts (always negative at the palni relative to the abraded reference site), included: 1) the minimuni standing potential level reached during the rest period ("minimum level" in Table 1 ); 2) the largest negative value for the preresponse levels; 3) the mean of the five potential levels just prior to the five largest positive-going skin potential responses (an estimate of the skin potential level during this period of repeated responding); 4) the largest breath-induced positive SPF: obtained during the series; 5) the mean of the five largest positive SPRs; and 6) the positive amplitude (SPR) of the balloon-startle response. The conductance measures (Table 2) , scored in microsiemen:~ per cm2, included: 7) the minimum conductance level, or highest resistance, developed by the skin with resting sweat glands; 8) the maximum skin conductance, or lowest resistance, in the record; 9) the mean of five conductance levels just prior to the five largest SCRs; 10) the largest breath-induced SCR; 11) the mean of the five largest breath-induced SCRs; and 12) the amplitude (SCR) of the balloon-startle response. cystic fibrosis patients showed more surface negative skin poten-fibrosis patients than in normal or asthmatic controls. All t test tial levels (variables 1 to 3) and larger positive SPRs (variables 4 comparisons were significant except those for cystics and normals to 6 ) than did the control groups. Similarly, higher (tonic) skin for variables 4, 6, and 12. conductance levels (variables 7 to 9) and larger (phasic) skin
The ability of electrodermal measures to discriminate between conductance responses (variables 10 to 12) were seen in cystic groups was examined further by stepwise multiple regression to determine the best one-, two-, and three-variable discriminations between the cystic fibrosis and asthmatic groups. As expected from the t test, the mean preresponse potential level (no. 3 in Table I ) provided the best one-variable discrimination, accounting for 60% of the diagnostic variance (R2 = 0.600). The twovariable model consisting of the mean preresponse potential level and the mean preresponse conductance level (no. 9 in Table 2 ) produced an R2 of 0.667. Adding the best third variable to create a three-variable model only increased the R2 by 0.019. Thus, a two-variable model seems most appropriate.
A visual representation of the separation between the two groups by the above two-variable model, mean potential level plotted against mean conductance level, is shown in Figure 3 . Cystic fibrosis patients tend to have higher levels ofboth standing potential and conductance than do controls and fall in the upper right portion of the graph, while asthmatic controls fall into the lower left portion.
Analysis for confounding factors. There were no differences within the 12 electrodermal variables when males were compared to females. A tendency toward higher conductance levels in younger cystic fibrosis subjects was not significant. When the electrodermal measures of the sweat-tested asthmatic controls were compared, there were no indications that an occult cystic was missed in the asthmatic control group.
Analysis of variance was used to determine whether medication influenced the electrodermal measures. Within the cystic fibrosis group, three medication classes were identified: 24 subjects were drug free, nine subjects were taking an adrenergic, and three were taking both an adrenergic and theophylline. There were four medication classes within the asthmatic group: six subjects were drug free, 19 were taking theophylline, 15 were taking an adrenergic and theophylline, and four were taking an adrenergic, theophylline, and a steroid. Both analyses did not show a statistically significant difference between drug classes for any of the 12 electrodermal variables.
Discriminant ana1j:si.s. The best two-variable prediction model (using the mean of five preresponse potential levels and the mean of five preconductance levels) was used to reassign the 82 individual patients to the cystic fibrosis or asthmatic groups with the
MEAN CONDUCTANCE LEVEL
( pS/crn2) Fig. 3 . Separation of cystic fibrosis patients (0, n = 37) and asthmatic controls (8. n = 45) by plotting the mean of five preresponse potential levels against the mean of five preresponse conductance levels for each individual. Four cystic fibrosis subject points and two asthmatic points Table 3 for the classification matrix). Thirty-three of 37 cystic fibrosis patients were correctly regrouped. Four were incorrectly reassigned as asthmatics, an 1 1 %; false-negative rate. Forty-three of the 45 asthmatics were correctly reassigned, a 4% false-positive rate.
DISCUSSION
Electrodermal measurements do not distinguish between normals and asthmatics, nor do they distinguish the heterozygote caniers of the cystic fibrosis gene (Fowles DC, unpublished data). However, they do compare favorably with the laboratory data obtained previously by Knowles et al. (10, 17) and by Quinton and Bijaman (9) for distinguishing between cystics and noncystics. Even though the sweat gland response to our series of breath stimuli could conceivably vary from subject to subject for psychological reasons, the largest preresponse level generated by stimulated sweat glands (-62.6 k 7.9 mV) agrees very closely with the nasal epithelium-flux chamber preparation maximum level (-53.0 k 1.8 mV) and the iontophoretically stimulated individual sweat droplet maximum potential level (-66.3 + 2.1 mV) for cystic fibrosis patients. Some of the variance can be explained by the inverse relationship between the potential level and the sweat rate, for which we did not control (1 8).
The minimum potential levels of Quinton and Bijamin (9) did not distinguish between groups, while there was an apparent difference in minimum SPLs in our subjects. There is probably no difference between groups with empty sweat glands. However, under the test conditions of this study, our pediatric patients were not able to adequately "rest." Hence, their sweat glands were probably not generating truly minimum levels.
Our results showed higher conductance in cystic fibrosis patients rather than the lower conductance previously reported by Knowles et al. (10) . This is because the factors involved in transepidermal conductance with eccrine sweat glands are different from those involved in mucous membrane conductance. With active sweat glands, the major contributor to palmar skin conductance is the salt bridge formed by sweat-filled ducts as they pass through the more resistant stratum corneum. The higher salt content of cystic sweat would conduct current eve11 more readily. It is also possible that the stratum corneum has a higher salt content in cystic fibrosis and that this nonsudorific pathway becomes more conductive as a result.
With regard to the question of which of these 12 variables provided the best discrimination between groups, several considerations point to the mean preresponse potential level. First, at a theoretic level this measure yields the best estimate of thc lumen-negative sweat gland sodium reabsorption potential, bein): obtained 1) when the sweat ducts are full and thus cany the ductal potential to the skin surface (i.e. there is a smaller voltage loss between the duct and the skin surface because of the lowered resistance associated with the duct filling) (12), and 2) when ductal sodium reabsorption is fully activated by duct filling. Second, the mean preresponse skin potential level yielded the largest F ratio in the comparison of the three groups (Table I) .
Third, it also yielded the largest t test value in the cystic-asthmatic comparisons and again in the cystic-normal comparisons.
Discriminant analysis with inclusion of all 114 patients in which measurements were attempted (50 cystic fibrosis patients, 54 asthmatics, and 10 controls) did not substantially increase the percentage of false-positives (6.370) although more cystic fibrosis patients were missed (22%).
It would simplify clinical procedures to use only the potential or only the conductance measures to distinguish between groups, since only one hand would be recorded and scored. However, subject reclassifi cation by discriminant analysis utilizing only the six potential or the six conductance measures lowered the accuracy of correct reclassification to 86% for potential and 77% for conductance measures, which indicates that both systems may need to be nieasured.
This first electrodermal study of an older pediatric population has demonstrated that a simplified, clinical technique has the potential for accurately discriminating between normal. asthmatic, and cystlc fibrosis patients possibly without large applied currents or the use of drugs to stimulate sweating.
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